Duloxetine Versus Placebo for Fibromyalgia
NCT00489073 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 345
Last updated 2007-06-21
Summary
The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with fibromyalgia.
Conditions
- Fibromyalgia
Interventions
- DRUG
-
duloxetine
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-11-30
- Completion
- 2003-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study for Adult Patients With Fibromyalgia
NCT00965081 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Duloxetine in the Treatment of Fibromyalgia
NCT00125892 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
NCT01237587 ·Status: COMPLETED ·Phase: PHASE3
-
An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)
NCT01621191 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for Adolescents With Fibromyalgia Syndrome
NCT01089621 ·Status: WITHDRAWN ·Phase: PHASE4
-
Duloxetine Metabolism and Fibromyalgia
NCT06866444 ·Status: RECRUITING
-
Duloxetine for the Treatment of Chronic Pelvic Pain
NCT01451606 ·Status: TERMINATED ·Phase: PHASE4
-
Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia
NCT03487211 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Assess Mechanisms in Peripheral Tissue Innervation for Fibromyalgia
NCT01127490 ·Status: COMPLETED ·Phase: NA
-
GW679769 In Fibromyalgia
NCT00264628 ·Status: COMPLETED
-
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
NCT00464737 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
NCT01077375 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Dolasetron in Patients With Fibromyalgia
NCT00820326 ·Status: COMPLETED ·Phase: PHASE3
-
Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed
NCT01619566 ·Status: WITHDRAWN ·Phase: PHASE4
-
A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.
NCT00612170 ·Status: COMPLETED ·Phase: PHASE3
-
Fibromyalgia and Naltrexone: The FINAL Study
NCT04270877 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
NCT04147858 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Pregabalin Combined With Toludesvenlafaxine in Patients With Fibromyalgia
NCT07208357 ·Status: RECRUITING ·Phase: NA
-
A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
NCT00357825 ·Status: COMPLETED ·Phase: PHASE2
-
Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
NCT00610610 ·Status: COMPLETED ·Phase: PHASE4
-
Fibromyalgia of Less Than One Year Duration. Study of Pregabalin
NCT01397006 ·Status: WITHDRAWN ·Phase: PHASE4
-
Genetic Variants Associated With Low Back Pain and Their Response to Treatment With Duloxetine or Propranolol
NCT03364075 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia
NCT00272207 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of TD-9855 to Treat Fibromyalgia
NCT01693692 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Efficacy of DVS-233 in Fibromyalgia
NCT00301431 ·Status: TERMINATED ·Phase: PHASE2/PHASE3